Literature DB >> 18816587

Synthesis and SAR study of T-type calcium channel blockers. Part II.

Yun Jeong Choe1, Han Na Seo, Soo Yeon Jung, Hyewhon Rhim, Jungahn Kim, Dong Joon Choo, Jae Yeol Lee.   

Abstract

3,4-Dihydroquinazoline derivatives have been known to be the novel and potent T-type calcium channel blockers. From a systematic variation of 3,4-dihydroquinazoline derivative 5c (KYS05043), plausible SAR results were established. It was revealed that a 5-(dimethylamino)pentylamino group at R(1), a biphenyl group at R(2), and a benzyl amido group at R(3)in the 3,4-dihydroquinazoline backbone are closely related with the channel selectivity (T/N-type) as well as the potency based on the discovery of 6k (KYS05090).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816587     DOI: 10.1002/ardp.200800079

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.

Authors:  Chris Bladen; Steven W McDaniel; Vinicius M Gadotti; Ravil R Petrov; N Daniel Berger; Philippe Diaz; Gerald W Zamponi
Journal:  ACS Chem Neurosci       Date:  2014-11-05       Impact factor: 4.418

2.  Synthesis of dihydroquinazolines from 2-aminobenzylamine: N 3 -aryl derivatives with electron-withdrawing groups.

Authors:  Nadia Gruber; Jimena E Díaz; Liliana R Orelli
Journal:  Beilstein J Org Chem       Date:  2018-09-26       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.